Wednesday, July 8, 2026

pharma · Pancreatic Adenocarcinoma · Cancer · ACTU

Actuate Therapeutics

Actuate Therapeutics trial registry — 12 ClinicalTrials.gov studies with program phase, status, and indication context.

1751 River Run, Suite 400, Fort Worth, Texas 76107, US HQ
2015 Founded
16 Employees
Public company Type
ACTU · NYSE Ticker
Company details
Status
Public
HQ
1751 River Run, Suite 400, Fort Worth, Texas 76107, US
Founded
2015
Employees
16
Programs
12
Drugs
11
Patents
7
Intelligence · Clinical Trials

Actuate Therapeutics clinical trials

Registry index of 12 ClinicalTrials.gov studies linked to Actuate Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Actuate Therapeutics trial registry — 12 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Actuate Therapeutics.

  1. 1801 — Phase 2

    Clinical update
  2. Retifanlimab — Phase 1

    Clinical update
  3. Megestrol acetate — Unknown

    Clinical update
  4. 9-ING-41 — Phase 2

    Clinical update
  5. 9-ING-41 — Phase 2

    Clinical update
  6. 9-ING-41 — Phase 2

    Clinical update
  7. 9-ING-41 — Phase 2

    Clinical update
  8. FOLFIRNINOX — Phase 2

    Clinical update

Trial registry

12 studies